Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia

Stem Cells

Volumn 31, Issue 5, 2013, Pages 882-894

  Cleveland, Susan M ^a   Smith, Stephen ^a   Tripathi, Rati ^a,b   Mathias, Elizabeth M ^a   Goodings, Charnise ^a   Elliott, Natalina ^a   Peng, Dunfa ^a   El Rifai, Wael ^a   Yi, Dajun ^a   Chen, Xi ^a   Li, Liqi ^c   Mullighan, Charles ^d   Downing, James R ^d   Love, Paul ^c   Davé, Utpal P ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Hematopoiesis; Leukemia; Stem cells; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LIM DOMAIN ONLY 2; LIM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; LEUKEMOGENESIS; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; T CELL LYMPHOBLASTIC LEUKEMIA; T LYMPHOCYTE; THYMOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; LEUKEMIA, T-CELL; LIM DOMAIN PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRECURSOR CELLS, T-LYMPHOID;

EID: 84876571061     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1345     Document Type: Article

References (52)

1. Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005;23:6306-6315. (Pubitemid 46218840)
2. Nam CH, Rabbitts TH. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion. Mol Ther 2006;13:15-25. (Pubitemid 41763479)
3. Van Vlierberghe P, Beverloo H, Buijs-Gladdines J et al. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2007;22:1434-1437. (Pubitemid 352006089)
4. Van Vlierberghe P, van Grotel M, Beverloo HB et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006;108:3520-3529.
5. Ferrando AA, Herblot S, Palomero T et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood 2004;103:1909-1911. (Pubitemid 38268990)
6. Mullighan CG, Phillips LA, Su X et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 2008;322:1377-1380. (Pubitemid 352775249)
7. Dave UP, Akagi K, Tripathi R et al. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet 2009;5:e1000491.
8. Neale GA, Rehg JE, Goorha RM. Disruption of T-cell differentiation precedes T-cell tumor formation in LMO-2 (rhombotin-2) transgenic mice. Leukemia 1997;11(suppl 3):289-290.
9. Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415-419. (Pubitemid 37296260)
10. Hacein-Bey-Abina S, Garrigue A, Wang GP et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCIDX1. J Clin Invest 2008;118:3132-3142.
11. Warren AJ, Colledge WH, Carlton MB et al. The oncogenic cysteinerich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994;78:45-57. (Pubitemid 24228299)
12. Yamada Y, Warren AJ, Dobson C et al. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 1998;95:3890-3895. (Pubitemid 28173224)
13. Meier N, Krpic S, Rodriguez P et al. Novel binding partners of Ldb1 are required for haematopoietic development. Development 2006;133:4913-4923.
14. Xu Z, Meng X, Cai Y et al. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins. Genes Dev 2007;21:942-955. (Pubitemid 46625643)
15. Wadman IA, Osada H, Grutz GG et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 1997;16:3145-3157. (Pubitemid 27234954)
16. Cai Y, Xu Z, Xie J et al. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors. Biochem Biophys Res Commun 2009;390:295-301.
17. Huang S, Qiu Y, Stein RW et al. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene 1999;18:4958-4967. (Pubitemid 29425302)
18. Osada H, Grutz GG, Axelson H et al. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1. Leukemia 1997;11(suppl 3):307-312.
19. Ferrando AA, Neuberg DS, Staunton J et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002;1:75-87. (Pubitemid 41039178)
20. Grutz GG, Bucher K, Lavenir I et al. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J 1998;17:4594-4605. (Pubitemid 28377160)
21. Love PE, Shores EW, Lee EJ et al. Differential effects of zeta and eta transgenes on early alpha/beta T cell development. J Exp Med 1994;179:1485-1494.
22. Nagy A. Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 2003:764.
23. Schmitt TM, Zuniga-Pflucker JC. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002;17:749-756. (Pubitemid 35477794)
24. Peng DF, Razvi M, Chen H et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 2009;58:5-15.
25. Paul WE. Fundamental immunology. Philadelphia: Lippincott Williams & Wilkins, 2003:1701.
26. Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000;182:311-322. (Pubitemid 30054364)
27. Fisch P, Boehm T, Lavenir I et al. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene 1992;7:2389-2397.
28. Li L, Leid M, Rothenberg EV. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 2010;329:89-93.
29. Wendorff AA, Koch U, Wunderlich FT et al. Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity 2010;33:671-684.
30. Weng AP, Ferrando AA, Lee W et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-271. (Pubitemid 39336870)
31. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001;2:731-737. (Pubitemid 33679835)
32. Marioni JC, Mason CE, Mane SM et al. RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008;18:1509-1517.
33. Mortazavi A, Williams BA, McCue K et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008;5:621-628. (Pubitemid 351911867)
34. Williams RT, Sherr CJ. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. Cold Spring Harb Symp Quant Biol 2008;73:461-467.
35. Oram SH, Thoms JA, Pridans C et al. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients. Oncogene 2010;29:5796-5808.
36. O'Neil J, Shank J, Cusson N et al. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 2004;5:587-596. (Pubitemid 38748920)
37. Herblot S, Steff A-M, Hugo P et al. SCL and LMO1 alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-T[α] chain expression. Nat Immunol 2000;1:138-144.
38. Chervinsky DS, Zhao XF, Lam DH et al. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: Parallels with E2A-deficient mice. Mol Cell Biol 1999;19:5025-5035. (Pubitemid 29289541)
39. Bain G, Engel I, Robanus Maandag EC et al. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 1997;17:4782-4791. (Pubitemid 27318153)
40. Wadman I, Li J, Bash RO et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J 1994;13:4831-4839. (Pubitemid 24319365)
41. Tatarek J, Cullion K, Ashworth T et al. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. Blood 2011;118:1579-1590.
42. Engel I, Murre C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J 2004;23:202-211. (Pubitemid 38165760)
43. Treanor LM, Volanakis EJ, Zhou S et al. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Blood 2011;117:5453-5462.
44. Garbe AI, Krueger A, Gounari F et al. Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med 2006;203:1579-1590. (Pubitemid 43877617)
45. Newrzela S, Cornils K, Li Z et al. Resistance of mature T cells to oncogene transformation. Blood 2008;112:2278-2286.
46. Mullighan CG, Goorha S, Radtke I et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007;446:758-764. (Pubitemid 46582031)
47. Zhang J, Ding L, Holmfeldt L et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012;481:157-163.
48. McCormack MP, Young LF, Vasudevan S et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 2010;327:879-883.
49. Infante A, Laresgoiti U, Fernandez-Rueda J et al. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle 2008;7:3915-3927.
50. Murga M, Fernandez-Capetillo O, Field SJ et al. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 2001;15:959-970.
51. Souroullas GP, Salmon JM, Sablitzky F et al. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 2009;4:180-186.
52. Li L, Jothi R, Cui K et al. Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells. Nat Immunol 2011;12:129-136.